Connor, Clark & Lunn Investment Management Ltd. Apyx Medical Corp Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$22 Billion
Q2 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2023 Aug 10, 2023	BUY	$2.75 - $7.59 $46,598 - $128,612	16,945 New	16,945 $85,000
Q2 2022 Aug 05, 2022	BUY	$3.11 - $7.5 $47,881 - $115,470	15,396 New	15,396 $90,000

Others Institutions Holding APYX

# of Institutions

Shares Held

14.3M

Call Options Held

360K

Put Options Held

Archon Capital Management LLC Seattle, WA

3.12M
Shares

$3.83 Million
3.44% of portfolio
Royce & Associates LP

2.5M
Shares

$3.07 Million
0.03% of portfolio
Vanguard Group Inc Valley Forge, PA

1.48M
Shares

$1.82 Million
0.0% of portfolio
Invenire Partners, LP Ridgefield, CT

946K
Shares

$1.16 Million
100.0% of portfolio
Horizon Kinetics Asset Management LLC

615K
Shares

$756,450
0.02% of portfolio

View Full List

About Apyx Medical Corp

Ticker APYX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 34,573,000
Market Cap $42.5M
Description
Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium to cut, coagulate and ab...

More about APYX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account